Can You Take Glycine and NAC Together?

Glycine and NAC (N-acetylcysteine) are not only safe to take together but are specifically studied as a combination supplement, often abbreviated “GlyNAC.” The pairing exists for a biochemical reason: both amino acids are precursors to glutathione, the body’s primary internal antioxidant, and neither works as well alone at restoring glutathione levels. A growing body of clinical research, mostly from trials in older adults, suggests the combination improves oxidative stress, mitochondrial function, inflammation, and insulin resistance. The evidence is promising enough to be worth understanding in detail, but the research is still young and comes largely from one lab group.

Why the Two Are Taken Together

Glutathione is built from three amino acids: glycine, cysteine, and glutamic acid. Your body assembles it inside cells, and it serves as one of the most important antioxidant molecules you produce. When researchers measured the intracellular levels of these three building blocks in older adults, they found that glycine and cysteine were both significantly lower than in younger people, while glutamic acid was not deficient.¹ That finding is the entire rationale for the combination: if two out of three raw materials are running low, supplementing just one of them only partially fixes the bottleneck. You need both.

NAC is not cysteine itself but a precursor that your body converts into cysteine after absorption. It has been used for decades in medicine, most famously as the antidote for acetaminophen (Tylenol) overdose. Glycine, meanwhile, is the simplest amino acid and plays roles in sleep, collagen formation, and neurotransmitter signaling beyond its glutathione duties. Each has its own independent uses, but the GlyNAC research specifically examines what happens when you supply both at once to support glutathione synthesis.

What the Clinical Trials Have Found

The most detailed evidence comes from a randomized, placebo-controlled trial in older adults conducted at Baylor College of Medicine. After supplementation, older participants who received GlyNAC showed improvements across a wide range of measures compared to those who got a placebo. The supplemented group corrected their glutathione deficiency, reduced oxidative stress, improved mitochondrial function (including the molecular regulation of that function), lowered inflammation, improved endothelial function, reduced insulin resistance, and showed improvements in several hallmarks associated with biological aging. Physical function also improved, as did waist circumference and systolic blood pressure.²

An earlier pilot trial over 24 weeks reported similarly broad results: GlyNAC corrected glutathione deficiency, lowered oxidative stress, and improved mitochondrial dysfunction, along with improvements in inflammation, endothelial dysfunction, insulin resistance, genomic damage, cognition, muscle strength, gait speed, exercise capacity, body fat, and waist circumference.³ The breadth of reported benefits is striking and worth noting honestly: when a supplement appears to improve nearly everything measured, it either works through a genuinely foundational mechanism or the study design is capturing noise. Glutathione deficiency is foundational enough that correcting it plausibly could cascade through multiple systems, but these results await replication by independent research groups.

The Metabolic Side of the Equation

One area with particularly concrete numbers involves metabolic health. A pilot study in patients with type 2 diabetes found that GlyNAC supplementation improved mitochondrial fat-burning capacity by about 30%, lowered a toxic byproduct called methylglyoxal by roughly 47%, reduced insulin resistance by about 22%, and lowered free fatty acids by around 25%.⁴ These are meaningful effect sizes for a nutritional intervention, though this was a small proof-of-concept study rather than a large clinical trial. The researchers framed these results as warranting further investigation, not as established treatment.

The insulin resistance improvement is particularly interesting because it ties into a broader pattern in the GlyNAC data. When mitochondria are not burning fat efficiently, excess fats build up in cells and interfere with insulin signaling. By restoring glutathione and improving mitochondrial function, the combination appears to address one of the upstream drivers of insulin resistance rather than just managing blood sugar directly. Whether this translates into meaningful clinical outcomes for people with diabetes is still an open question that larger trials need to answer.

Brain Health and Cognitive Function

Some of the most dramatic numbers in the GlyNAC literature come from animal studies on the brain. In old mice supplemented with GlyNAC for eight weeks, brain glutathione levels rose substantially: total glutathione was about 156% higher and the active (reduced) form was roughly 204% higher compared to unsupplemented old mice. Importantly, these levels were statistically comparable to those seen in young mice, suggesting the supplementation essentially restored youthful glutathione concentrations in the brain.⁵ The same study also found improvements in oxidative stress, glucose uptake, and neurotrophic factors in the brain, and the mice’s cognitive performance improved significantly.⁶

The human pilot trial mentioned earlier also reported cognitive improvements in older adults taking GlyNAC for 24 weeks.³ The brain is especially vulnerable to oxidative stress because of its high oxygen consumption and relatively limited antioxidant reserves, so boosting glutathione there could be meaningful. But mouse brain studies don’t automatically translate to human outcomes, and the human cognitive data so far comes from small trials without the kind of detailed neuropsychological testing that would make neurologists sit up.

The Longevity Data in Mice

One finding that has generated attention in the longevity research community involves lifespan. Mice receiving a GlyNAC-supplemented diet lived about 24% longer than control mice on a regular diet, with similar effects in both males and females.⁷ That is a large effect for a nutritional intervention in rodents, comparable to what some caloric restriction protocols achieve.

The obvious caveat: mice are not people, and many interventions that extend mouse lifespan have failed to show equivalent effects in humans. The study is useful for understanding the mechanism, since the supplemented mice also showed corrections in glutathione deficiency, oxidative stress, mitochondrial dysfunction, nutrient sensing pathways, and genomic damage, all processes that deteriorate with age. But nobody should take GlyNAC expecting to live 24% longer based on a mouse study.

Dosing, Safety, and What the Trials Used

A dedicated dose-finding trial tested GlyNAC at three daily doses in 114 healthy older volunteers: a low dose of 2.4 grams per day, a medium dose of 4.8 grams per day, and a high dose of 7.2 grams per day, all using a 1:1 ratio of glycine to NAC. The supplement was safe and well tolerated across all dose levels. No severe adverse effects were reported, and no participants dropped out because of side effects.⁸

The longer clinical trials in older adults typically used doses in the range of roughly 1.2 grams each of glycine and NAC taken twice daily, amounting to a total of about 4.8 grams per day. The 1:1 weight ratio of glycine to NAC appears to be the standard used across studies. If you are looking at commercial GlyNAC supplements, check whether the label reflects this pairing and total dose.

Glycine on its own is considered very safe at supplemental doses and is naturally present in collagen-rich foods. NAC has a somewhat more complicated safety profile. Common minor side effects of NAC include nausea, vomiting, and gastrointestinal discomfort, especially at higher doses or when taken on an empty stomach. These effects tend to be dose-dependent and are more common with NAC alone than when it’s part of a GlyNAC formulation, though the trials specifically studying the combination reported good tolerability.

Who Actually Benefits the Most

Here is where the story gets more nuanced than the headlines suggest. That dose-finding trial of 114 healthy older adults measured whether GlyNAC supplementation actually increased glutathione levels as its primary endpoint. For the overall group, it did not. There was no significant difference in glutathione levels between the supplemented groups and the placebo group after two weeks.⁸

However, a closer look at the data revealed something important. When researchers examined the subset of participants who had both high oxidative stress and low baseline glutathione, the medium and high doses of GlyNAC did significantly increase glutathione levels.⁸ This makes biological sense: if your glutathione levels are already adequate, adding more raw materials doesn’t do much because the system is not bottlenecked. The people who benefit are those whose glutathione synthesis is actually impaired, whether from aging, chronic disease, or other metabolic stress.

This finding is worth taking seriously before spending money on supplements. A healthy 30-year-old with no particular oxidative stress burden may not see meaningful changes from GlyNAC. The clearest evidence of benefit comes from older adults, people with type 2 diabetes, and those with conditions that deplete glutathione. If you are younger and healthy, your body is likely already making enough glutathione from the amino acids in your diet.

Drug Interactions to Watch For

The most clinically significant interaction with NAC involves nitroglycerin, a medication used for angina and certain heart conditions. NAC potentiates the blood-vessel-relaxing effects of nitroglycerin, which sounds harmless in theory but can cause dangerous drops in blood pressure. In one study of patients with unstable angina, symptomatic hypotension occurred in seven patients receiving the nitroglycerin-NAC combination versus zero in the nitroglycerin-only group.⁹ The effect is specifically due to NAC’s thiol group, which enhances how nitroglycerin works on blood vessel walls.¹⁰

This interaction extends to other organic nitrate medications as well. NAC accentuates the physiological actions of nitrates even in people who have not developed tolerance to them.¹¹ If you take any form of nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate, adding NAC (with or without glycine) without medical supervision could be genuinely dangerous. This is not a theoretical concern — the effect is well-documented and clinically significant.

Beyond nitrates, NAC can theoretically interact with other blood-pressure-lowering medications and blood thinners. People on anticoagulants, immunosuppressants, or chemotherapy drugs should discuss NAC with their prescriber. The glycine component of GlyNAC has far fewer interaction concerns, but glycine can enhance the sedative effects of certain medications since it acts as an inhibitory neurotransmitter.

NAC’s Wider Use in Mental Health

Independent of the GlyNAC combination, NAC alone has been investigated across a surprisingly broad range of psychiatric conditions. Through its antioxidant, anti-inflammatory, and glutamate-modulating effects, researchers have tested it as an add-on treatment in schizophrenia, bipolar disorder, depression, anxiety, obsessive-compulsive disorder, substance-use disorders, and autism. The strongest evidence for benefit currently exists for the negative symptoms of schizophrenia (like apathy and social withdrawal), severe autism, depression, and obsessive-compulsive and related disorders, where NAC appears to help as an adjunctive agent alongside standard treatments.¹²

These psychiatric applications generally use NAC alone rather than GlyNAC, and the mechanism is somewhat different: in the brain, NAC influences glutamate signaling through the cystine-glutamate antiporter, a pathway distinct from its glutathione-boosting role. The doses used in psychiatric research tend to be higher than those in the GlyNAC aging studies, often in the range of 2,000 to 3,000 milligrams of NAC daily. If you are interested in NAC for mental health rather than aging or antioxidant support, that body of literature operates somewhat independently from the GlyNAC research, and the addition of glycine may or may not be relevant to those specific outcomes.

How GlyNAC Supplementation Compares to Glutathione Supplements

A reasonable question is why not just take glutathione directly. After all, if the goal is to raise glutathione levels, swallowing the finished product seems more efficient than taking its precursors. The problem is that oral glutathione gets broken down in your digestive tract before most of it reaches your cells. Even liposomal formulations, which use fat-based packaging to protect the molecule during digestion, have limited evidence for reliably raising intracellular glutathione levels to the degree that precursor supplementation achieves.

The GlyNAC approach works differently. By providing the raw materials, it lets your cells manufacture glutathione on their own terms, inside the cell where it’s needed. The research found that supplementation corrected deficiencies in both intracellular glycine and cysteine, restoring the cell’s own glutathione synthesis machinery rather than trying to force the finished product through from the outside.¹ Even a short two-week course was enough to correct intracellular deficiencies in glycine and cysteine, restore glutathione synthesis, and lower oxidative stress in older adults. This precursor strategy has a better mechanistic rationale than direct glutathione supplementation, and the clinical data consistently supports it.

Some people take NAC alone without glycine, which also supports glutathione synthesis since cysteine is often considered the rate-limiting amino acid. But the research underpinning GlyNAC specifically argues that glycine deficiency is a separate and underappreciated bottleneck, especially in aging. Supplementing NAC alone would correct one deficiency while leaving the other in place. Whether this matters in practice for younger, well-nourished individuals is unclear, but for older adults the case for combining both is stronger than for either alone.

Practical Timing and Stomach Tolerance

Neither the published trials nor the researchers behind them have made strong claims about optimal timing, and no study has directly compared morning versus evening dosing for GlyNAC. Most trial protocols split the daily dose into two servings, which is consistent with how amino acid supplements are generally used to maintain steadier blood levels throughout the day.

If you experience nausea from NAC, taking it with food usually helps, though this may slightly slow absorption. Glycine, by contrast, is well tolerated on an empty stomach and is sometimes taken before bed because of its mild calming effect on the nervous system. There is no pharmacological conflict between taking them simultaneously, and the clinical trials administered them together as a combined supplement. Some people prefer powder forms mixed into water, which can reduce the pill burden since the total daily dose amounts to several grams of material. The powder also tends to be cheaper per gram than encapsulated versions.

One practical note: NAC has a distinctive sulfurous smell, sometimes compared to rotten eggs. This is normal and reflects its sulfur-containing cysteine backbone. Glycine, by comparison, has a mildly sweet taste and is virtually odorless. Combining them in a single drink can mask some of NAC’s less pleasant qualities, which is a minor but real advantage of the combination format over taking NAC capsules separately.